West Pharmaceutical Services Inc
WSTNYSECIK 105770HealthcareFiscal year ends Dec 31
Reports and events: 332 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:17 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000105770-26-000121 |
| 2026-10-2907:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000118 |
| 2026-10-2617:14 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000105770-26-000114 |
| 2026-07-2316:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000105770-26-000099 |
| 2026-07-2307:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000097 |
| 2026-07-1416:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000105770-26-000093 |
| 2026-06-0116:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000080 |
| 2026-05-2016:04 ET | 8-K/A | 1.05 Material cybersecurity incident; 9.01 Financial statements and exhibits | 0000105770-26-000077 |
| 2026-05-1117:06 ET | 8-K | 1.05 Material cybersecurity incident; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000068 |
| 2026-05-0516:49 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-26-000056 |
| 2026-04-2316:12 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000105770-26-000049 |
| 2026-04-2307:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000047 |
| 2026-03-1208:31 ET | DEF 14A | Proxy statementPeriod 2026-05-04 | 0001104659-26-026778 |
| 2026-03-0916:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000041 |
| 2026-02-1716:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000105770-26-000010 |
| 2026-02-1207:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000005 |
| 2025-10-2316:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000105770-25-000093 |
| 2025-10-2307:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000090 |
| 2025-09-1116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000083 |
| 2025-07-2416:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000105770-25-000065 |
| 2025-07-2407:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000062 |
| 2025-07-2116:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000058 |
| 2025-05-1216:46 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000043 |
| 2025-05-0816:46 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-25-000039 |
| 2025-04-2416:19 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000105770-25-000036 |
| 2025-04-2407:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000031 |
| 2025-04-2407:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000029 |
| 2025-04-1416:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000022 |
| 2025-03-2116:05 ET | DEF 14A | Proxy statementPeriod 2025-05-06 | 0001558370-25-003461 |
| 2025-03-1116:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000019 |
| 2025-02-1816:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000105770-25-000013 |
| 2025-02-1308:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000007 |
| 2024-12-1316:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000105770-24-000088 |
| 2024-12-1116:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000084 |
| 2024-10-2416:21 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000105770-24-000081 |
| 2024-10-2407:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000075 |
| 2024-10-0716:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-24-000071 |
| 2024-07-2516:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000105770-24-000066 |
| 2024-07-2508:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000060 |
| 2024-07-0807:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000105770-24-000055 |
| 2024-04-2616:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-24-000035 |
| 2024-04-2516:24 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000105770-24-000031 |
| 2024-04-2507:42 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000025 |
| 2024-03-1308:31 ET | DEF 14A | Proxy statementPeriod 2024-04-23 | 0001558370-24-003056 |
| 2024-02-2016:44 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000105770-24-000015 |
| 2024-02-1507:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000009 |
| 2023-11-3016:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000105770-23-000075 |
| 2023-10-2616:26 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000105770-23-000068 |
| 2023-10-2607:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-23-000064 |
| 2023-09-2116:33 ET | 8-K/A | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-23-000054 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:13 ET. Listed shows no prices and gives no investment advice.